Pyxis Oncology, Inc. (PYXS)
NASDAQ · Healthcare
Pyxis Oncology, Inc. Income Statement 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 13.9M | 16.1M |
| Gross Profit | 11.5M | 15.7M |
| Profitability | ||
| Operating Income | -84.4M | -89.5M |
| EBITDA | -79.9M | -86.5M |
| Net Income | -79.6M | -77.3M |
| Per Share Data | ||
| EPS (diluted) | $-1.28 | $-1.32 |
| Shares Outstanding (dil.) | 62M | 58M |
Pyxis Oncology, Inc. Income Statement — FAQ
Pyxis Oncology, Inc. (PYXS) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PYXS's income statement history?
The chart and table above show Pyxis Oncology, Inc.'s income statement by year and by quarter, including the growth rate.